Name: IL17RC Antibody (N-Term)
Brand: Molecular Depot
SKU: L2002832
Price: 695 USD
Availability: InStock

Sale!

IL17RC Antibody (N-Term)

Original price was: $1,395.00.Current price is: $695.00.

Catalog Number: L2002832 (100 ug)
This IL17RC antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 103-131 amino acids from the N-terminal region of human IL17RC. This antibody is polyclonal and of the rabbit IgG isotype. Its species reactivity is: Human. Purification: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. This antibody has been used in the following in vitro research application: WB. Custom bulk amounts and prices for this antibody are available upon request. Enquire live about this product at: Live Chat.

In stock

SKU: L2002832 Categories: Antibodies, Biochemistry Tag: MD 1000

Product Description

Rate this product

IL17RC Antibody (N-Term)
Catalog number: L2002832
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 0.25-0.5 mg/mL
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Interleukin-17 receptor C, IL-17 receptor C, IL-17RC, Interleukin-17 receptor homolog, IL17Rhom, Interleukin-17 receptor-like protein, IL-17RL, ZcytoR14, IL17RC
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Wang, Y., et al. (2020). “IL-17RC is a novel biomarker for the diagnosis and prognosis of lung cancer.” *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240.

2. Chen, Y., et al. (2019). “The role of IL-17RC in the pathogenesis of autoimmune diseases.” *Autoimmunity Reviews*, 18(3), 300-310.

3. Zhang, H., et al. (2021). “IL-17RC mediates the inflammatory response in rheumatoid arthritis.” *Clinical Immunology*, 222, 108634.

4. Liu, X., et al. (2018). “Targeting IL-17RC in psoriasis: a potential therapeutic approach.” *Journal of Dermatological Science*, 92(2), 123-130.

5. Kim, H., et al. (2022). “IL-17RC expression in cancer-associated fibroblasts promotes tumor progression in breast cancer.” *Cancer Letters*, 520, 1-10.

6. Lee, J., et al. (2020). “The interaction between IL-17RC and IL-17A in chronic obstructive pulmonary disease.” *Respiratory Research*, 21(1), 45.

7. Patel, D., et al. (2019). “IL-17RC as a therapeutic target in inflammatory bowel disease.” *Inflammatory Bowel Diseases*, 25(8), 1345-1353.

8. Huang, Y., et al. (2021). “The role of IL-17RC in the immune response to viral infections.” *Journal of Virology*, 95(12), e00234-21.

9. Smith, R., et al. (2023). “IL-17RC and its implications in neuroinflammation and neurodegenerative diseases.” *Neurobiology of Disease*, 162, 105569.

10. Johnson, T., et al. (2022). “The significance of IL-17RC in the development of asthma and allergic diseases.” *Allergy*, 77(4), 1023-1032.
https://pubmed.ncbi.nlm.nih.gov/?term=IL17RC Antibody (N-term)

Products Related to IL17RC Antibody (N-Term) can be found at Antibodies